In the last trading session, 0.14 million shares of the Palvella Therapeutics Inc (NASDAQ:PVLA) were traded, and its beta was -0.12. Most recently the company’s share price was $23.72, and it changed around $1.61 or 7.28% from the last close, which brings the market valuation of the company to $262.24M. PVLA currently trades at a discount to its 52-week high of $29.27, offering almost -23.4% off that amount. The share price’s 52-week low was $6.20, which indicates that the current value has risen by an impressive 73.86% since then.
Palvella Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended PVLA as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.
Palvella Therapeutics Inc (NASDAQ:PVLA) trade information
Instantly PVLA has showed a green trend with a performance of 7.28% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 24.39 on recent trading dayincreased the stock’s daily price by 2.75%. The company’s shares are currently up 97.67% year-to-date, but still up 7.57% over the last five days. On the other hand, Palvella Therapeutics Inc (NASDAQ:PVLA) is -6.87% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $45, which translates to bulls needing to increase their stock price by 47.29% from its current value. Analyst projections state that PVLA is forecast to be at a low of $30 and a high of $52.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.57%. Palvella Therapeutics Inc earnings are expected to increase by 61.98% in 2025, but the outlook is positive 18.74% per year for the next five years.
PVLA Dividends
Palvella Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
LYNX1 CAPITAL MANAGEMENT LP, with 1.9542% or 43499.0 shares worth $0.43 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ROYCE FUND-Royce Smaller-Companies Growth Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 71.49 shares worth $1.7 million, making up 0.65% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 44.14 shares worth around $1.05 million, which represents about 0.40% of the total shares outstanding.
